Pharmaceutical industry teams with artificial intelligence (AI) to speed drug discovery

Artificial intelligence (AI) is no longer advancing in baby steps. In fact, it's starting to leap forward and sprint toward the future. Its recent applications in medicine have been remarkable, especially as a diagnostic tool. For instance, AI can detect melanoma -- a form of skin cancer -- in its early stages, allowing quick response and increased survival rates -- up to 98 per cent! AI is now also able to diagnose diabetic retinopathy (DR) -- a form of blindness caused by diabetes.